期刊文献+

中国胰岛素分泌研究组第十五次会议——2017年度报告 被引量:2

原文传递
导出
摘要 中国胰岛素分泌研究组( China Group on Insulin Secretion, CGIS)第十五次会议于2017年4月15日在六朝古都南京的玄武湖畔召开,会议由CGIS主办,施维雅(天津)制药有限公司独家赞助. 这次会议的主题是"胰路有你,加倍守护",100多位来自全国各地糖尿病领域的专家共聚一堂,共同探讨有关β细胞功能和胰岛素分泌的最新进展及其体会.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2017年第12期1087-1090,共4页 Chinese Journal of Endocrinology and Metabolism
  • 相关文献

参考文献1

  • 1Jin Liu,Lingling Bian,Li Ji,Yang Chen,Heng Chen,Yong Gu,Bingqin Ma,Wei Gu,Xinyu Xu,Yun Shi,Jian Wang,Dalong Zhu,Zilin Sun,Jianhua Ma,Hui Jin,Xing Shi,Heng Miao,Bing Xin,Yan Zhu,Zhenwen Zhang,Ruifang Bu,Lan Xu,Guangde Shi,Wei Tang,Wei Li,Dongmei Zhou,Jun Liang,Xingbo Cheng,Bimin Shi,Jixiang Dong,Ji Hu,Chen Fang,Shao Zhong,Weinan Yu,Weiping Lu,Chenguang Wu,Li Qian,Jiancheng Yu,Jialin Gao,Xiaoqiang Fei,Qingqing Zhang,Xueqin Wang,Shiwei Cui,Jinluo Cheng,Ning Xu,Guofeng Wang,Guoqing Han,Chunrong Xu,Yun Xie,Minmin An,Wei Zhang,Zhixiao Wang,Yun Cai,Qi Fu,Yu Fu,Shuai Zheng,Fan Yang,Qingfang Hu,Hao Dai,Yu Jin,Zheng Zhang,Kuanfeng Xu,Yifan Li,Jie Shen,Hongwen Zhou,Wei He,Xuqin Zheng,Xiao Han,Liping Yu,Jinxiong She,Mei Zhang,Tao Yang.The heterogeneity of islet autoantibodies and the progression of islet failure in type 1 diabetic patients[J].Science China(Life Sciences),2016,59(9):930-939. 被引量:5

二级参考文献35

  • 1Achenbach P., Warncke K., Reiter J., Naserke H.E., Williams A.J.K., Bingley P.J., Bonifacio E., Ziegler A.G.. Stratification of Type 1 Diabetes Risk on the Basis of Islet Autoantibody Characteristics. Diabetes, 2004, 53: 384-392.
  • 2Epstein F.H., Atkinson M.A., Maclaren N.K.. The Pathogenesis of Insulin-Dependent Diabetes Mellitus. N Engl J Med, 1994, 331: 1428-1436.
  • 3Baekkeskov S., Aanstoot H.J., Christgai S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., Camilli P.D.. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature, 1990, 347: 151-156.
  • 4Beck R.W., Tamborlane W.V., Bergenstal R.M., Miller K.M., DuBose S.N., Hall C.A.. The T1D Exchange Clinic Registry. J Clinical Endocrinology Metabolism, 2012, 97: 4383-4389.
  • 5Besser, R.E., Shields, B.M., Casas, R., Hattersley, A.T., and Ludvigsson, J. (2013). Lessons from the mixed-meal tolerance test. Diabetes Care, 195–201.
  • 6Bingley P.J., Gale E.A.M.. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia, 2006, 49: 881-890.
  • 7Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E.. Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J Immunol, 1995, 155: 5419-5426.
  • 8Bottazzo G.F., Florin-Christensen A., Doniach D.. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet, 1974, 2: 1279-1283.
  • 9Christie M.R., Molvig J., Hawkes C.J., Carstensen B., Mandrup-Poulsen T.. IA-2 Antibody-Negative Status Predicts Remission and Recovery of C-Peptide Levels in Type 1 Diabetic Patients Treated With Cyclosporin. Diabetes Care, 2002, 25: 1192-1197.
  • 10Eisenbarth G.S.. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med, 1986, 314: 1360-1368.

共引文献4

同被引文献12

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部